Madrigal Pharmaceuticals

Madrigal Pharmaceuticals

World Rank (Aug-2026)
1943
Market Cap (Aug-2026)
11.727 Billion USD
World Rank (Jan-05-2024)
3,310
Market Cap (Jan-05-2024)
4.308 Billion USD
World Rank (Jul-30-2023)
3,701
Market Cap (Jul-30-2023)
3.759 Billion USD
World Rank (Jan-07-2022)
8,034
Market Cap (Jan-07-2022)
1.321 Billion USD
World Rank (Jan-01-2021)
5,949
Market Cap (Jan-01-2021)
1.719 Billion USD
Headquarters Country
USA
Top Healthcare Companies in USA
Top Pharmaceutical Companies in USA
Nasdaq / NYSE Code
MDGL
Employee Count
92
Employee Count as of Date
As on 2022
Headquarters City/State
Pennsylvania
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
958 Million USD
Annual Operating Income in USD
-300 Million USD
Annual Net Income in USD
-288 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
1,260 Million USD
Total Liabilities in USD
657 Million USD
Total Equity in USD
603 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Biotechnology
Company Website
MADRIGAL PHARMACEUTICALS INC
Yahoo
Yahoo @ Nasdaq
Company Profile

Madrigal Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver which is a key regulatory mechanism common to a spectrum of cardio metabolic and fatty liver diseases with high unmet medical need. The headquarters is in USA.

Annual Results Summary

MADRIGAL PHARMACEUTICALS - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-20220-293 (Loss)-295 (Loss)
Dec-20210-242 (Loss)-241 (Loss)
Dec-20200-206 (Loss)-202 (Loss)
Dec-20190-94 (Loss)-83 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 362 Million USD.

Total Liabilities as on Dec-2022 was 165 Million USD.

Total Equity as on Dec-2022 was 197 Million USD.

IPO Year
2007
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share